The hepatitis B virus X protein downregulates NF-κB signaling pathways through decreasing the Notch signaling pathway in HBx-transformed L02 cells

Luo,Jing; Zhou,Haiyan; Wang,Fan; Xia,Xiumei; Sun,Qian; Wang,Ronghua; Cheng,Bin

doi:10.3892/ijo.2013.1842

The hepatitis B virus X protein downregulates NF-κB signaling pathways through decreasing the Notch signaling pathway in HBx-transformed L02 cells

Authors:
- Jing Luo
- Haiyan Zhou
- Fan Wang
- Xiumei Xia
- Qian Sun
- Ronghua Wang
- Bin Cheng
View Affiliations

Affiliations: Department of Gastroenterology and Hepatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China
Published online on: February 27, 2013 https://doi.org/10.3892/ijo.2013.1842
Pages: 1636-1643

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatitis B virus X protein (HBx) is implicated in the pathogenesis of hepatocellular carcinoma, which has been found to be associated with Notch and NF-κB signaling. This study aimed to investigate the crosstalk between Notch and NF-κB pathways in HBx-related hepatocellular carcinoma. An HBx-transformed non-tumor hepatic cell line L02 (L02/HBx) was previously established. Immunofluorescence assays were performed to visualize HBx and the Notch intracellular domain (NICD) in cell nuclei. Co-immunoprecipitation assays were used to investigate physical interactions between HBx and components of the Notch signaling pathway (NICD and JAG1), NF-κB signaling pathway (p65 and p50) or IκBα. L02/HBx cells were treated with the Notch signal inhibitor DAPT or Notch1 siRNA to inhibit the Notch1 pathway. qRT-PCR was used to quantify the expression of the p65, p50 and IκBα genes. Protein expression changes in cytoplasm and nuclei after treatment with DAPT or Notch1 siRNA were analyzed by western blotting and EMSA assays. We found that HBx directly regulated Notch1 signaling, which cross-talked with the NF-κB pathway. Downregulation of Notch1 decreased the binding of NF-κB p65 to its target gene promoter, reduced NF-κB expression and enhanced IκBα expression. The results suggest that HBx functions through the Notch signaling pathway; Notch contributes to hepatocarcinogenesis partially by regulating the NF-κB pathway. Our findings provide new insights into the role of Notch and NF-κB signaling in the progression of hepatocellular carcinoma related to HBx.

View Figures

View References

1.	Jemal A, Bray F, Melissa M, et al: Global Cancer Statistics. CA Cancer J Clin. 55:74–108. 2005. View Article : Google Scholar
2.	Hashem BE and Rudolph KL: Hepatocellular carcinoma epidemiology and molecular carcinogenesis. Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar
3.	Feitelson MA and Duan LX: Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol. 150:1141–1157. 1997.PubMed/NCBI
4.	Wang F, Zhou H, Xia X, et al: Activated Notch signaling is required for hepatitis B virus X protein to promote proliferation and survival of human hepatic cells. Cancer Lett. 298:64–73. 2010. View Article : Google Scholar : PubMed/NCBI
5.	Lai EC: Notch signaling: control of cell communication and cell fate. Development. 131:965–973. 2004. View Article : Google Scholar : PubMed/NCBI
6.	Miele L: Notch signaling. Clin Cancer Res. 12:1074–1079. 2006. View Article : Google Scholar : PubMed/NCBI
7.	Miele L, Golde T and Osborne B: Notch signaling in cancer. Curr Mol Med. 6:905–918. 2006. View Article : Google Scholar : PubMed/NCBI
8.	Kopan R and Ilagan MX: Gamma-secretase: proteasome of the membrane? Nat Rev Mol Cell Biol. 5:499–504. 2004. View Article : Google Scholar : PubMed/NCBI
9.	Berman JN and Look AT: Targeting transcription factors in acute leukemia in children. Curr Drug Targets. 8:727–737. 2007. View Article : Google Scholar : PubMed/NCBI
10.	Rangarajan A, Talora C, Okuyama R, et al: Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J. 20:3427–3436. 2001. View Article : Google Scholar : PubMed/NCBI
11.	Ronchini C and Capobianco AJ: Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic). Mol Cell Biol. 1:5925–5934. 2001. View Article : Google Scholar : PubMed/NCBI
12.	Baonza A and Freeman M: Control of cell proliferation in the Drosophila eye by Notch signaling. Dev Cell. 8:529–539. 2005. View Article : Google Scholar : PubMed/NCBI
13.	Cheng P, Zlobin A, Volgina V, et al: Notch-1 regulates NF-kappaB activity in hemopoietic progenitor cells. J Immunol. 167:4458–4467. 2001. View Article : Google Scholar : PubMed/NCBI
14.	Klinakis A, Szabolcs M, Politi K, et al: Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice. Proc Natl Acad Sci USA. 103:9262–9267. 2006. View Article : Google Scholar : PubMed/NCBI
15.	Diao J, Garces R and Richardson CD: X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. Cytokine Growth Factor Rev. 12:189–205. 2001. View Article : Google Scholar
16.	Seto E, Mitchell PJ and Yen TS: Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature. 344:72–74. 1990. View Article : Google Scholar : PubMed/NCBI
17.	Lucito R and Schneider RJ: Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C. J Virol. 66:983–991. 1992.PubMed/NCBI
18.	Meyer M, Caselmann WH, Schluter V, et al: Hepatitis B virus transactivator MHBst: activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization. EMBO J. 11:2991–3001. 1992.PubMed/NCBI
19.	Campbell KJ and Perkins ND: Regulation of NF-kappaB function. Biochem Soc Symp. 73:165–180. 2006.
20.	Perkins ND: Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 8:49–62. 2007. View Article : Google Scholar : PubMed/NCBI
21.	Maniati E, Bossard M, Cook N, et al: Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits PPARγ expression and promotes pancreatic cancer progression in mice. J Clin Invest. 121:4685–4699. 2011.
22.	Pan H, Zhou W, He W, et al: Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway. Int J Mol Med. 30:337–343. 2012.PubMed/NCBI
23.	Schwarzer R, Dörken B and Jundt F: Notch is an essential upstream regulator of NF-κB and is relevant for survival of Hodgkin and Reed-Sternberg cells. Leukemia. 26:806–813. 2012.PubMed/NCBI
24.	Cheng B, Zheng Y, Guo XR, et al: Hepatitis B viral X protein alters the biological features and expressions of DNA repair enzymes in LO2 cells. Liver Int. 30:319–326. 2010. View Article : Google Scholar : PubMed/NCBI
25.	Wang Z, Banerjee S, Ahmad A, et al: Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathways. PLoS One. 6:e205372011.PubMed/NCBI
26.	Berasain C, Castillo J, Perugorria MJ, et al: Infammation and liver cancer: new molecular links. Ann NY Acad Sci. 1155:206–221. 2009. View Article : Google Scholar : PubMed/NCBI
27.	Lupberger J and Hildt E: Hepatitis B virus-induced concogenesis. World J Gastroenterol. 13:74–81. 2007. View Article : Google Scholar : PubMed/NCBI
28.	Qiao L, Zhang H, Yu J, et al: Constitutive activation of NF-kappaB in human hepatocellular carcinoma: evidence of a cytoprotective role. Hum Gene Ther. 17:280–290. 2006. View Article : Google Scholar : PubMed/NCBI
29.	Gao J, Chen C, Hong L, et al: Expression of Jagged1 and its association with hepatitis B virus X protein in hepatocellular carcinoma. Biochem Biophys Res Commun. 356:341–347. 2007. View Article : Google Scholar : PubMed/NCBI
30.	Karin M: NF-kappaB and cancer: mechanisms and targets. Mol Carcinog. 45:355–361. 2006. View Article : Google Scholar : PubMed/NCBI
31.	Luedde T and Schwabe RF: NF-κB in the liver - linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 8:108–118. 2011.
32.	Beg AA and Baldwin JR: The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev. 7:2064–2070. 1993. View Article : Google Scholar : PubMed/NCBI
33.	Oakley F, Mann J, Ruddell RG, et al: Basal expression of IkappaBalpha is controlled by the mammalian transcriptional repressor RBP-J (CBF1) and its activator Notch1. J Biol Chem. 278:24359–24370. 2003. View Article : Google Scholar : PubMed/NCBI
34.	Monsalve E, Ruiz-García A, Baladrón V, et al: Notch1 upregulates LPS-induced macrophage activation by increasing NF-kappaB activity. Eur J Immunol. 39:2556–2570. 2009. View Article : Google Scholar : PubMed/NCBI